Interestingly, an aging-associated reduction of TAK1 expression was shown to cooperate with other genetic risk factors to promote the RIPK1-dependent onset of neuroinflammation and the development of amyotrophic lateral sclerosis (ALS) in humans (Xu et al., 2018). Here, MAP3K7 is linked to amyotrophic lateral sclerosis.